Table 2. 2009 Sentinel village assessment for nodule, Mf, and OV16 prevalence among adults (persons aged ≥20 years).
Nodule | Mf | OV16 | ||||||
LGA | village | tested | Positive | % positive | positive | % positive | positive | % positive |
Karu | Gurku | 134 | 0 | 0.00% | 0 | 0.00% | 0 | 0.00% |
Kokona | Arusu | 108 | 1 | 0.90% | 0 | 0.00% | 5 | 4.63% |
Bassa | Bakin Kogi Lemoro | 160 | 0 | 0.00% | 0 | 0.00% | 2 | 1.25% |
Bassa | Mafara | 125 | 5 | 4.00% | 0 | 0.00% | 7 | 5.60% |
Bokkos | Kamwai | 110 | 2 | 1.80% | 2 | 1.82% | 12 | 10.91% |
Jos East | Godong | 102 | 0 | 0.00% | 0 | 0.00% | 0 | 0.00% |
Total | 739 | 8 | 1.08% | 2 | 0.27% | 26 | 3.52% |